Skip to main content

Table 1 Summary of tumor development in FVB mice injected with RM11A stable transfectants

From: ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis

 

RM11A+Dox

RM11A+Dox/ErbB2

Number of mice injected

38

31

Number of palpable tumors

29

42

Number of tumors per mouse

0.76

1.35

Average tumor latency (d)

47.9

22.1a

  1. a Significantly lower than RM11A-+Dox (p < 0.001)